abstract |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to the field of medicine. Composition containing microparticles of glucagons-like peptide 1 (GLP-1) in combination with diketopiperazine (DKP) is stable in vitro and in vivo. Composition may be used as pharmaceutical preparation to treat diseases or conditions, including, but not limited to, diabetes, cancer and obesity. ^ EFFECT: invention provides for minimum risk in case of intrapulmonic administration. ^ 24 cl, 31 dwg, 20 ex |